Both in Pharmaceuticals
Neuphoria Therapeutics vs Kyntra Bio
Over the past year NEUP returned −17.4% and KYNB returned −50.3%; their daily moves had a correlation of 0.13.
NEUP −17.4% KYNB −50.3%Growth of $1, one year, split-adjusted
| Metric | NEUP | KYNB |
|---|---|---|
| Price | $3.36 | $4.72 |
| Market cap | $18.2M | $19.1M |
| Today | −0.89% | +4.89% |
| 1 month | −5.9% | −30.5% |
| 6 months | −35.3% | −33.0% |
| Year to date | −13.4% | — |
| 1 year | −25.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 21.4% | 56.1% |
| Short % of float | 0.1% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).